We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+19.44%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.11B
AUM Growth
+$33.3M
Cap. Flow
-$6.36M
Cap. Flow %
-0.57%
Top 10 Hldgs %
54.13%
Holding
78
New
4
Increased
24
Reduced
16
Closed
4
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPRX icon
26
OptimizeRx
OPRX
$114M
$14.8M 1.33%
1,010,931
+649,655
+180% +$10.9M
CUTR
27
DELISTED
Cutera, Inc.
CUTR
$13.5M 1.21%
569,868
+2,729
+0.5% +$87.2K
KIDS icon
28
OrthoPediatrics
KIDS
$519M
$13.4M 1.2%
301,579
-1,152
-0.4% -$50.9K
INSM icon
29
Insmed
INSM
$21.4B
$12.8M 1.15%
750,883
+1,913
+0.3% +$37.2K
TCMD icon
30
Tactile Systems Technology
TCMD
$635M
$11.5M 1.03%
+700,000
New +$9.75M
SCTL
31
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$10.6M 0.96%
8,916,870
+345,000
+4% +$454K
XENE icon
32
Xenon Pharmaceuticals
XENE
$6.06B
$10M 0.9%
+279,444
New +$10.3M
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$2.45B
$9.45M 0.85%
235,777
+1,478
+0.6% +$63.4K
SONX
34
DELISTED
Sonendo, Inc.
SONX
$8.37M 0.75%
4,185,619
MXCT icon
35
MaxCyte
MXCT
$112M
$6.75M 0.61%
1,364,222
-1,121
-0.1% -$5.52K
GMAB icon
36
Genmab
GMAB
$17.7B
$6.04M 0.54%
160,025
-238
-0.1% -$9.15K
BMRN icon
37
BioMarin Pharmaceuticals
BMRN
$11.6B
$5.98M 0.54%
61,482
-59,459
-49% -$6.16M
PFE icon
38
Pfizer
PFE
$143B
$5.78M 0.52%
141,547
-214
-0.2% -$9.24K
ABCM
39
DELISTED
Abcam PLC
ABCM
$5.11M 0.46%
379,711
+77
+0% +$1.15K
GH icon
40
Guardant Health
GH
$21.5B
$4.8M 0.43%
204,845
+41
+0% +$1.17K
MIRO
41
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$3.75M 0.34%
2,234,656
+1,700,000
+318% +$4.42M
CSTL icon
42
Castle Biosciences
CSTL
$849M
$3.67M 0.33%
161,618
+14
+0% +$342
STVN icon
43
Stevanato
STVN
$5.42B
$2.99M 0.27%
+115,356
New +$2.47M
AKU
44
DELISTED
Akumin Inc
AKU
$2.41M 0.22%
3,539,498
-24,766
-0.7% -$24.4K
SLP icon
45
Simulations Plus
SLP
$369M
$1.57M 0.14%
35,703
-50
-0.1% -$2K
HUM icon
46
Humana
HUM
$43.7B
$431K 0.04%
888
TAK icon
47
Takeda Pharmaceutical
TAK
$54.6B
$422K 0.04%
25,630
SNN icon
48
Smith & Nephew
SNN
$13.3B
$422K 0.04%
15,111
SNY icon
49
Sanofi
SNY
$103B
$420K 0.04%
7,711
IART icon
50
Integra LifeSciences
IART
$1.29B
$417K 0.04%
7,261

Similar funds

First Light Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, First Light Asset Management held 78 positions worth $1.11B, up 3.1% from $1.08B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

First Light Asset Management's Q1 2023 filing shows 4 new, 24 increased, 16 reduced and 4 closed positions. Its largest new stake was Orthofix Medical: 2,650,971 shares worth $44.4M. The largest sale was SeaSpine Holdings Corporation Common Stock, an estimated $57.4M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 86% a quarter earlier, followed by Communication Services.

  • First Light Asset Management's largest Q1 2023 buy was Orthofix Medical: 2,650,971 shares worth $44.4M.
  • First Light Asset Management added most to Karuna Therapeutics, Inc. Common Stock in Q1 2023, an estimated $15.1M increase.
  • First Light Asset Management's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $27.9M.
  • First Light Asset Management fully exited SeaSpine Holdings Corporation Common Stock in Q1 2023, selling an estimated $57.4M.
  • First Light Asset Management's ten largest holdings make up 54% of its $1.11B portfolio in Q1 2023.
  • First Light Asset Management opened 4 new positions and closed 4 in Q1 2023.
  • First Light Asset Management's portfolio value rose 3.1% quarter-over-quarter to $1.11B.

Based on First Light Asset Management's 13F filing for Q1 2023, filed 15 May 2023.